The production of nitric oxide in EL4 lymphoma cells overexpressing growth hormone

Journal of Neuroimmunology

Volumn 134, Issue 1-2, 2003, Pages 82-94

  Arnold, Robyn E ^a   Weigent, Douglas A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Growth hormone; Lymphoma; Nitric oxide; Overexpression; Protection

Indexed keywords

ARGINASE; ARGININE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; ISOENZYME; MESYLIC ACID METHYL ESTER; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL PROTECTION; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENOTOXICITY; HORMONE ACTION; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STRESS;

ANIMALS; ARGININE; CARBOCYANINES; CARBONYL CYANIDE P-TRIFLUOROMETHOXYPHENYLHYDRAZONE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; GROWTH HORMONE; IMMUNE SYSTEM; LYMPHOCYTES; LYMPHOMA; MEMBRANE POTENTIALS; METHYL METHANESULFONATE; MICE; MITOCHONDRIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PROTEIN TRANSPORT; RECEPTORS, SOMATOTROPIN; STRESS;

EID: 0037222147     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00420-4     Document Type: Article

References (91)

1. Argetsinger L.S., Carter-Su C. Mechanism of signaling by growth hormone receptor. Physiol. Rev. 76:1996;1089-1107.
2. Arkins S., Dantzer R., Kelley K.W. Somatolactogens, somatomedins, and immunity. J. Dairy Sci. 76:1993;2437-2450.
3. Baeuerle P.A., Henkel T. Function and activation of NF-KB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
4. Baixeras E., Jeay S., Kelly P.A., Postel-Vinay M.C. The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the pro-B Ba/F3 cell line. Endocrinology. 142:2001;2968-2977.
5. Baxter J.B., Blalock J.E., Weigent D.A. Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone. Endocrinology. 129:1991;1727-1734.
6. Benfield M.R., Vail A., Bucy R.P., Weigent D.A. Growth hormone induces IFN-gamma production and may play a role in the presentation of alloantigens in vitro. Neuroimmunomodulation. 4:1997;19-27.
7. Berczi I. The role of the growth and lactogenic hormone family in immune function. Neuroimmunomodulation. 1:1994;201-216.
8. Camps M., Nichols A., Gillieron C., Antonsson B., Muda M., Chabert C., Boschert U., Arkinstall S. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science. 280:1998;1262-1265.
9. Cassidy R.A., Burleson D.G., Dalgado A.V., Kohler D.J., Salin M.L., Pruitt B.A. Effects of heme proteins on nitric oxide levels and cell viability in isolated PMNs: a mechanism of toxicity. J. Leukoc. Biol. 67:2000;357-368.
10. Chang R.-H., Feng M.H., Liu W.H., Lai M.Z. Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology. 90:1997;364-369.
11. Chang C.-I., Liao J.C., Kuo L. Arginase modulates nitric oxide production in activated macrophages. Am. J. Physiol. 274:1998;H342-H348.
12. Cifone M.G., D'Alo S., Parroni R., Millimaggi D., Biordi L., Martinotti S., Santoni A. Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-γ production. J. Leukoc. Biol. 93:1999;3876-3884.
13. Clancy R.M., Amin A.R., Abramson S.B. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 41:1998;1141-1151.
14. Corraliza L.M., Campo M.L., Soler G., Modolell M. Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods. 174:1994;231-235.
15. Costoya J.A., Finidori J., Moutoussamy S., Senaris R., Devesa J., Arce V.M. Activation of growth hormone receptor delivers an antiapoptotic signal: evidence for a role of Akt in this pathway. Endocrinology. 140:1999;5937-5943.
16. Crow J.P., Beckman J.S. The role of peroxynitrite in nitric oxide-mediated toxicity. Curr. Top. Microbiol. Immunol. 196:1995;57-73.
17. Dalton T.P., Shertzer H.G., Puga A. Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol. 39:1999;39-67.
18. Dimmeler S., Haendeler J., Nehls M., Zeiher A.M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein. J. Exp. Med. 185:1997;601-607.
19. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 399:1999;601-605.
20. Doi S.Q., Jacot T.A., Sellitti D.F., Hirszel P., Hirata M.H., Striker G.E., Striker L.J. Growth hormone increases inducible nitric oxide synthase expression in mesangial cells. J. Am. Soc. Nephrol. 11:2000;1419-1425.
21. Ducrocq C., Blanchard B., Pignatelli B.O.H. Peroxynitrite: an endogenous oxidizing and nitrating agent. Cell. Mol. Life Sci. 55:1999;1068-1077.
22. Efron D.T., Kirk S.J., Regan M.C., Wasserkrug H., Barbul A. Nitric oxide generation from L-arginine is required for optimal human peripheral blood lymphocyte DNA synthesis. Surgery. 110:1991;327-334.
23. Finkel T. Signal transduction by reactive oxygen species in non-phagocytic cells. J. Leukoc. Biol. 65:1999;337-340.
24. Flescher E., Ledbetter J.A., Schieven G.L., Vela-Roch N., Fossum D., Dung H., Ogawa N., Talal N. Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J. Immunol. 153:1994;4880-4889.
25. Fu Y.K., Arkins S., Wang B.S., Kelley K.W. A novel role of growth hormone and insulin-like growth factor: priming neutrophils for superoxide anion secretion. J. Immunol. 146:1991;1602-1608.
26. Fulton D., Gratton J.-P.M.J., Fontana J., Fujio Y., Walsh K., Franke T.F. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 399:1999;597-601.
27. Gannett P.M., Ye J., Ding M., Powell J., Zhang Y., Darian E., Daft J., Shi X. Activation of AP-1 through the MAP kinase pathway: a potential mechanism of the carcinogenic effect of arenediazonium ions. Chem. Res. Toxicol. 13:2000;1020-1027.
28. Goren A.C.F., Mayer B. The versatile and complex enzymology of nitric oxide synthase. Biochemistry (Mosc.). 63:1998;734-743.
29. Granger D.L., Taintor R.R., Boockvar K.S., Hibbs J.B. Jr. Measurement of nitrate and nitrite in biological samples using nitrite reductase and Greiss reaction. Methods Enzymol. 268:1996;142-151.
30. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
31. Haeffner A., Deas O., Mollereau B., Estaquier J., Mignon A., Haeffner-Cavaillon N., Charpentier B., Senik A., Hirsch F. Growth hormone prevents human monocytic cells from Fas-mediated apoptosis by up-regulating Bcl-2 expression. Eur. J. Immunol. 29:1999;334-344.
32. Hattori N., Shimatsu A., Sugita M., Kumagai S., Imura H. Immunoreactive growth hormone (GH) secretion by human lymphocytes: augmented release by exogenous GH. Biochem. Biophys. Res. Commun. 168:1990;396-401.
33. Inoue S., Kawanishi S. Oxidative damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett. 371:1995;86-88.
34. Jeay S., Sonenshein G.E., Postel-Vinay M.C., Baixeras E. Growth hormone prevents apoptosis through activation of nuclear factor-kB in interleukin-3-dependent Ba/F3 cell line. Mol. Endocrinol. 14:2000;650-661.
35. Jeay S., Sonenshein G.E., Kelly P.A., Postel-Vinay M.C., Baixeras E. Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kB and phosphatidyllinositol 3-kinase. Endocrinology. 142:2001;147-156.
36. Kamata H., Hirata H. Redox regulation of cellular signalling. Cell. Signal. 11:1999;1-14.
37. Kao T.L., Supowit S.C., Thompson E.A., Meyer W.J. III Immunoreactive growth hormone production by human lymphocyte cell lines. Cell. Mol. Neurobiol. 12:1992;483-498.
38. Kelley K.W. Growth hormone, lymphocytes and macrophages. [Review] Biochem. Pharmacol. 38:1989;705-713.
39. Kim Y.M., Talanian R.V., Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3 activity via two distinct mechanisms. J. Biol. Chem. 272:1997;25502-25507.
40. Kolbus A., Herr I., Schreiber M., Debatin K.-M., Wagner E.F., Angel P. c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents. Mol. Cell. Biol. 20:2000;575-582.
41. Lander H.M., Jacovina A.T., Davis R.J., Tauras J.M. Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J. Biol. Chem. 271:1996;19705-19709.
42. Li P.-F., Dietz R., vonHarsdorf R. p53 Regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18:1999;6027-6036.
43. Lytras A., Quan N., Vrontakis M.E., Shaw J.E., Cattini P.A., Friesen H.G. Growth hormone expression in human Burkitt lymphoma serum-free Ramos cell line. Endocrinology. 132:1993;620-628.
44. Macouillard-Poulletier de Gannes F., Belaud-Rotureau M., Voisin P., Leducq N., Belloc F., Canioni P., Diolez P. Flow cytometric analysis of mitochondrial activity in situ: application to acetylceramide-induced mitochondrial swelling and apoptosis. Cytometry. 33:1998;333-339.
45. Mannick J.B., Asano K., Izumi K., Kieff E., Stamler J.S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79:1994;1137-1146.
46. Mannick J.B., Miao X.Q., Stamler J.S. Nitric oxide inhibits Fas-induced apoptosis. J. Biol. Chem. 272:1997;24125-24128.
47. Marks-Konczalik J., Chu S.C., Moss J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor κB-binding sites. J. Biol. Chem. 273:1998;22201-22208.
48. Matsuda T., Saito H., Inoue T., Fukatsu K., Han I., Furukawa S., Ikeda S., Muto T. Growth hormone inhibits apoptosis and upregulates reactive oxygen intermediate production by human polymorphonuclear neutrophils. Core J. Parenter. Enter. Nutr. 22:1998;368-374.
49. Mellado M., Llorente M., Rodriguez-Frade M., Lucas P., Martinez A.C., delReal G. HIV-1 envelope protein gp120 triggers a Th2 response in mice that shifts to Th1 in the presence of human growth hormone. Vaccine. 15:1998;1111-1115.
50. Mercola K.E., Cline M.J., Golde D.W. Growth hormone stimulation of normal and leukemic human T-lymphocyte proliferation in vitro. Blood. 58:1981;337-340.
51. Metivier D., Dallaporta B., Zamzami N., Larochette N., Susin S., Marao I., Kroemer G. Cytofluorometric detection of mitochondrial alterations in early CD95/Fas/APO-1-triggered apoptosis of Jurkat T lymphoma cells. Comparison of seven mitochondrion-specific fluorochromes. Immunol. Lett. 61:1998;157-163.
52. Modollel M., Corraliza I.M., Link F., Soler G., Eichmann K. Reciprocal regulation of the nitric oxide synthase/argninase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 25:1995;1101-1104.
53. Müller J.M., Rupec R.A., Baeuerle P.A. Study of gene regulation by NF-KB and AP-1 in response to reactive oxygen intermediates. Methods: A Companion to Methods Enzymol. 11. 1998;301-312.
54. Nakatsubo N., Kojima H., Kikuchi K., Nagoshi H., Hirata Y., Maeada D., Imai Y., Irimura T., Nagano T. Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescent indicators: diaminofluoresceins. FEBS Lett. 427:1998;263-266.
55. Niandong L., Hichem C., Mertani C.N.G., Tornell J., Lobie P.E. Mode of the autocrine/paracrine mechanism of growth hormone action. Exp. Cell Res. 237:1997;196-206.
56. L blocks activation of related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2 and stress-activated kinase/c-Jun N-terminal protein kinase in the cellular response to methylmethane sulfonate. J. Biol. Chem. 274:1999;8618-8623.
57. Pinilla L., Tena-Sepmpere M., Aguilar E. Nitric oxide stimulates growth hormone secretion in vitro through a calcium- and cyclic guanosine monophosphate-independent mechanism. Horm. Res. 51:1999;242-247.
58. Rao K.M.K., Padmanabhan J., Kilby D.L., Cohen H.J., Currie M.S., Weinberg J.B. Flow cytometric analysis of nitric oxide production in human neutrophils using dichlorofluorescein diacetate in the presence of a calmodulin inhibitor. J. Leukoc. Biol. 51:1992;496-500.
59. Re R. The origins of intracrine hormone action. Am. J. Med. Sci. 323:2002;43-48.
60. Reisser D., Lagadec P., Arnould L., Onier N., Maupoil V., Pinard D., Jeannin J.-F. Nitric oxide inhibits proliferation but increases life-span of T lymphocytes in tumour-bearing rats. Cancer Immunol. Immunother. 46:1998;160-166.
61. Rohn W.M., Weigent D.A. Cloning and nucleotide sequencing of rat lymphocyte growth hormone cDNA. Neuroimmunomodulation. 2:1995;108-114.
62. Rossig L., Haendeler J., Hermann C., Malchow P., Urbich C., Zeiher A., Dimmeler S. Nitric oxide downregulates MKP-3 mRNA levels. Involvement in endothelial cell protection from apoptosis. J. Biol. Chem. 275:2000;25502-25507.
63. Rottenberg H., Wu S. Quantitative assay of flow cytometry of the mitochondrial membrane potential in intact cells. Biochim. Biophys. Acta. 1404:1998;393-404.
64. 2+ during growth hormone-induced priming of human neutrophils. Brain Behav. Immun. 11:1997;39-46.
65. Saxena Q.B., Saxena R.K., Adler W.H. Regulation of natural killer activity in vivo: III. Effect of hypophysectomy and growth hormone treatment on the natural killer activity of the mouse spleen cell population. Int. Arch. Allergy Appl. Immunol. 67:1982;169-174.
66. Schimpff R.M., Repellin A.M. Production of interleukin-1-alpha and interleukin-2 by mononuclear cells in healthy adults in relation to different experimental conditions and to the presence of growth hormone. Horm. Res. 33:1990;171-176.
67. Schwartz Y., Kostyo J.L., Goodman H.M. Growth hormone (GH) increases nitric oxide (NO) production in rat adipocytes. The Endo Soc 77th Ann Meeting OR26-1. vol. 79:2002;. Ref Type: Abstract.
68. Sciorati C., Rovere P., Ferrarini M., Heltai S., Manfredi A.A., Clementi E. Autocrine nitric oxide modulates CD95-induced apoptosis in γδ T lymphocytes. J. Biol. Chem. 272:1997;23211-23215.
69. Seeburg P.H., Shine J., Martial J., Baxter J.D., Goodman H.M. Nucleotide sequence and amplification in bacteria of a structural gene to rat GH. Nature. 270:1977;486-494.
70. Simmons W.W., Closs E.I., Cunningham J.M., Smith T.W., Kelly R.A. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-argnine transport and NO production by CAT-1, CAT-2A, and CAT-2B. J. Biol. Chem. 271:1996;11694-11702.
71. Smith G.J., Grisham G.W., Fatteh M.M. Kinetics of cell death induced in IDT 1/2 cells by methyl methanesulfonate and the effects of extracellular calcium on cell death. Am. J. Pathol. 122:1986;492.
72. Snow E.C., Feldbush T.L., Oaks J.A. The effect of growth hormone and insulin upon MLC responses and the generation of cytotoxic lymphocytes. J. Immunol. 126:1981;161-164.
73. Spadoni G.L., Spagnoli A., Cianfarani S., DelPrincipe D., Menichelli A., DiGiulio S., Boscherini B. Enhancement by growth hormone of phorbol diester-stimulated respiratory burst in human polymorphonuclear leukocytes. Acta Endocrinol. 124:1991;589-594.
74. Stuchr D.J. Structure-function aspects in the nitric oxide synthases. Annu. Rev. Pharmacol. Toxicol. 37:1997;339-359.
75. Taub D.D., Tsarfaty G., Lloyd A.R., Durum S.K., Longo D.L., Murphy W.J. Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. J. Clin. Invest. 94:1994;293-300.
76. Taylor-Robinson A.W. Counter-regulation of T helper 1 cell proliferation by nitric oxide and interleukin-2. Biochem. Biophys. Res. Commun. 233:1997;14-19.
77. Taylor-Robinson A.W. Inhibition of IL-2 production by nitric oxide: a novel self-regulatory mechanism for Th1 cell proliferation. Immunol. Cell Biol. 75:1997;167-175.
78. Thomsen L.L., Ching L.M., Baguley B.C. Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthene-4-acetic acid. Cancer Res. 50:1990;6966-6970.
79. Tsumori M., Murakami Y., Koshimura K., Kato Y. Endogenous nitric oxide inhibits growth hormone secretion through cyclic guanosine monophosphate-dependent mechanisms in GH3 cells. Endocr. J. 46:1999;779-785.
80. Varma S., Sabharwal P., Sheridan J.F., Malarkey W.B. Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay. J. Clin. Endocrinol. Metab. 76:1993;49-53.
81. 2. J. Immunol. 154:1995;1909-1918.
82. Weigent D.A. Immunoregulatory properties of growth hormone and prolactin. J. Pharmacol. Ther. 69:1996;237-257.
83. Weigent D.A., Baxter J.B., Wear W.E., Smith L.R., Bost K.L., Blalock J.E. Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J. 2:1988;2812-2818.
84. Weigent D.A., Blalock J.E., LeBoeuf R.D. An antisense oligodeoxynucleotide to growth hormone messenger ribonucleic acid inhibits lymphocyte proliferation. Endocrinology. 128:1991;2053-2057.
85. Weigent D.A., Baxter J.B., Blalock J.E. The production of growth hormone and insulin-like growth factor-I by the same subpopulation of rat mononuclear leukocytes. Brain Behav. Immun. 6:1992;365-376.
86. Wickman A., Jonsdottir I.H., Bergstrom G., Hedin L. GH and IGF-1 regulate the expression of endothelial nitric oxide synthase (eNOS) in cardiovascular tissues of hypophysectomized female rats. Eur. J. Endocrin. 147:2002;523-533.
87. Wiedermann C.J., Niedermühlbichler M., Geissler D., Beimpold H., Braunsteiner H. Priming of normal human neutrophils by recombinant human growth hormone. Br. J. Haematol. 78:1991;19-22.
88. Wiedermann C.J., Reinisch N., Kahler C., Geisen F., Zilian U., Herold M., Braunsteiner H. In vivo activation of circulating monocytes by exogenous growth hormone in man. Brain Behav. Immun. 6:1992;387-393.
89. Wu G., Morris S.M. Jr. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336:1998;1-17.
90. Zamzami N., Marchetti P., Castedo M., Zanin C., Voyssiere J., Petit P., Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1995;1661-1672.
91. Zhu T., Goh L.K.E., Graichen R., Ling L., Lobie P. Signal transduction via the growth hormone receptor. Cell. Signal. 13:2001;599-616.